Early studies of p53 function and the consequences of TP53 mutation demonstrated that p53 regulates DNA-damage-induced cell cycle checkpoints and inactivation of which enables genomic instability2–4, indicating that p53 acts as the “guardian of the genome” which prevents cells from developing potentially tumor-promoting mutations and abnormal genomes5. The gene discussed is TP53; the disease is neoplasm.